Literature DB >> 1315381

Phosphatidylinositol kinase is reduced in Alzheimer's disease.

J Jolles1, J Bothmer, M Markerink, R Ravid.   

Abstract

Phosphatidylinositol (PI) kinase and PI phosphate (PIP) kinase activities were measured in postmortem samples of brain tissue from patients with Alzheimer's disease and nondemented control subjects. A membrane-free cytosolic fraction from four neocortical locations, with exogenous inositol lipids as the substrate, was used. Tissue from patients with Alzheimer's disease was characterized by reduced PIP formation; the reduction was 50% in prefrontal cortex, temporal cortex, and parietal cortex and 40% in precentral gyrus. In contrast, no alterations were found in PI bisphosphate formation in these four neocortical locations. The specific changes in PI kinase but not PIP kinase activity suggest that the findings may have functional relevance to the involvement of brain membrane processes in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315381     DOI: 10.1111/j.1471-4159.1992.tb10981.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Histological assessment of cerebellar granule cell layer in postmortem brain; a useful marker of tissue integrity?

Authors:  Donna Sheedy; Antony Harding; Meichien Say; Julia Stevens; Jillian J Kril
Journal:  Cell Tissue Bank       Date:  2011-06-28       Impact factor: 1.522

Review 2.  Tied up: Does altering phosphoinositide-mediated membrane trafficking influence neurodegenerative disease phenotypes?

Authors:  Sravanthi S P Nadiminti; Madhushree Kamak; Sandhya P Koushika
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

3.  Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease.

Authors:  Jennifer S Yokoyama; Yunpeng Wang; Andrew J Schork; Wesley K Thompson; Celeste M Karch; Carlos Cruchaga; Linda K McEvoy; Aree Witoelar; Chi-Hua Chen; Dominic Holland; James B Brewer; Andre Franke; William P Dillon; David M Wilson; Pratik Mukherjee; Christopher P Hess; Zachary Miller; Luke W Bonham; Jeffrey Shen; Gil D Rabinovici; Howard J Rosen; Bruce L Miller; Bradley T Hyman; Gerard D Schellenberg; Tom H Karlsen; Ole A Andreassen; Anders M Dale; Rahul S Desikan
Journal:  JAMA Neurol       Date:  2016-06-01       Impact factor: 18.302

4.  Genetic interactions within inositol-related pathways are associated with longitudinal changes in ventricle size.

Authors:  Mary Ellen I Koran; Timothy J Hohman; Shashwath A Meda; Tricia A Thornton-Wells
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

5.  Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model.

Authors:  Frédéric Calon; Giselle P Lim; Fusheng Yang; Takashi Morihara; Bruce Teter; Oliver Ubeda; Phillippe Rostaing; Antoine Triller; Norman Salem; Karen H Ashe; Sally A Frautschy; Greg M Cole
Journal:  Neuron       Date:  2004-09-02       Impact factor: 17.173

6.  Decrease in cerebral inositols in rats and humans.

Authors:  R A Moats; Y H Lien; D Filippi; B D Ross
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

7.  Hippocampal lipid differences in Alzheimer's disease: a human brain study using matrix-assisted laser desorption/ionization-imaging mass spectrometry.

Authors:  Lakshini H S Mendis; Angus C Grey; Richard L M Faull; Maurice A Curtis
Journal:  Brain Behav       Date:  2016-07-14       Impact factor: 2.708

8.  Aβ inhibits SREBP-2 activation through Akt inhibition.

Authors:  Amany Mohamed; Anissa Viveiros; Kathleen Williams; Elena Posse de Chaves
Journal:  J Lipid Res       Date:  2017-11-09       Impact factor: 5.922

9.  Regulation of amyloid precursor protein processing by serotonin signaling.

Authors:  Anna A Pimenova; Amantha Thathiah; Bart De Strooper; Ina Tesseur
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.